Fabian Benjamin Christoffer Nordin
Plus aucun poste en cours
Profil
Fabian Benjamin Christoffer Nordin formerly worked at Biosergen AS, as Director, JP Nordiska AB, as Principal, Kaupthing Sverige AB, as Analyst, Kaupthing Bank A, as Principal, and Karolinska Development AB, as Investor & Media Relations Contact in 2013.
Mr. Nordin received his graduate degree from the University of Uppsala.
Anciens postes connus de Fabian Benjamin Christoffer Nordin
| Sociétés | Poste | Fin |
|---|---|---|
| Kaupthing Sverige AB | Analyst-Equity | - |
Kaupthing Bank A/S
 Kaupthing Bank A/S Major BanksFinance Kaupthing Bank A/S is an international bank. The company is based in Copenhagen, Denmark. Kaupthing Bank was acquired by Føroya Sparikassi from Kaupþing ehf on December 30, 2004. | Corporate Officer/Principal | - |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Directeur/Membre du Conseil | - |
JP Nordiska AB
 JP Nordiska AB Investment Banks/BrokersFinance JP Nordiska AB provides investment banking services. The company also provides brokerage services. The company is headquartered in Stockholm, Sweden | Corporate Officer/Principal | - |
| KAROLINSKA DEVELOPMENT AB | Investor Relations Contact | - |
Formation de Fabian Benjamin Christoffer Nordin
| University of Uppsala | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| Entreprise privées | 4 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
JP Nordiska AB
JP Nordiska AB Investment Banks/BrokersFinance JP Nordiska AB provides investment banking services. The company also provides brokerage services. The company is headquartered in Stockholm, Sweden | Finance |
Kaupthing Bank A/S
Kaupthing Bank A/S Major BanksFinance Kaupthing Bank A/S is an international bank. The company is based in Copenhagen, Denmark. Kaupthing Bank was acquired by Føroya Sparikassi from Kaupþing ehf on December 30, 2004. | Finance |
| Kaupthing Sverige AB | Finance |